Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States

To examine demographic and geographic variation in the use of ranibizumab and bevacizumab for the treatment of neovascular age-related macular degeneration (AMD) among Medicare beneficiaries.

Source: American Journal of Ophthalmology - October 27, 2017 Category: Opthalmology Authors: Emily W. Gower, Joshua D. Stein, Nakul S. Shekhawat, Shravani Mikkilineni, Taylor S. Blachley, Nicholas M. Pajewski Tags: Original Articles Source Type: research